Relmada Therapeutics, Inc. (RLMD)
4.52
+0.45
(+11.06%)
USD |
NASDAQ |
Sep 11, 16:00
4.62
+0.10
(+2.21%)
After-Hours: 20:00
Relmada Therapeutics Total Assets (Quarterly) : 219.06M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 219.06M |
| March 31, 2026 | 235.36M |
| December 31, 2025 | 94.00M |
| September 30, 2025 | 14.88M |
| June 30, 2025 | 21.12M |
| March 31, 2025 | 27.68M |
| December 31, 2024 | 45.82M |
| September 30, 2024 | 55.72M |
| June 30, 2024 | 71.03M |
| March 31, 2024 | 84.41M |
| December 31, 2023 | 97.55M |
| September 30, 2023 | 109.15M |
| June 30, 2023 | 122.04M |
| March 31, 2023 | 135.57M |
| December 31, 2022 | 152.91M |
| September 30, 2022 | 187.12M |
| June 30, 2022 | 215.77M |
| March 31, 2022 | 225.81M |
| December 31, 2021 | 223.33M |
| September 30, 2021 | 90.93M |
| June 30, 2021 | 110.77M |
| March 31, 2021 | 103.87M |
| December 31, 2020 | 118.19M |
| September 30, 2020 | 125.60M |
| June 30, 2020 | 134.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 115.42M |
| June 30, 2019 | 10.22M |
| March 31, 2019 | 2.604M |
| December 31, 2018 | 3.299M |
| September 30, 2018 | 1.556M |
| June 30, 2018 | 3.048M |
| March 31, 2018 | 4.796M |
| December 31, 2017 | 6.574M |
| September 30, 2017 | 5.614M |
| June 30, 2017 | 2.837M |
| March 31, 2017 | 4.170M |
| December 31, 2016 | 6.225M |
| September 30, 2016 | 7.922M |
| June 30, 2016 | 10.24M |
| March 31, 2016 | 12.72M |
| December 31, 2015 | 16.60M |
| September 30, 2015 | 20.48M |
| June 30, 2015 | 24.39M |
| March 31, 2015 | 27.85M |
| December 31, 2014 | 32.79M |
| September 30, 2014 | 27.85M |
| August 31, 2014 | |
| May 31, 2014 | |
| February 28, 2014 | 0.01M |
| September 30, 2013 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.50M |
| Shareholders Equity (Quarterly) | 206.56M |
| Current Ratio | 29.52 |